57 New Models of Resistant Melanoma for Preclinical Assays von Robichon, C, Annereau, J.P, Gomes, B, Pillon, A, De Vries, L, Cussac, D, Meyer, N, Lamant, L, Kruczynski, A, Guilbaud, N

Volltext

285 Antiproliferative Activity of F, a Novel Polyamine-vectorized Drug, on Resistant Cancer Cells von Brel, V, Créancier, L, Marionneau-Brossard, M.L, Offrete, V, Verdier, J, Andre, K, Fournier, E, Kruczynski, A, Guilbaud, N, Annereau, J.P

Volltext

Novel tetra-acridine derivatives as dual inhibitors of topoisomerase II and the human proteasome von Vispé, S., Vandenberghe, I., Robin, M., Annereau, J.P., Créancier, L., Pique, V., Galy, J.P., Kruczynski, A., Barret, J.M., Bailly, C.

Volltext

Establishment of Novel Preclinical Melanoma Models Resistant to Vemurafenib von Robichon, C., Annereau, J.P., Gomes, B., Pillon, A., de Vries, L., Cussac, D., Meyer, N., Lamant, L., Kruczynski, A., Guilbaud, N.

Volltext

111 POSTER Design of a screening procedure to select patients with leukemia for treatment with F 14512, a novel targeted cytotoxic agent von Barret, J.M, Annereau, J.P, Brel, V, Broussas, M, Guminski, Y, Imbert, T, Dumontet, C, Goetsch, L, Guilbaud, N, Bailly, C

Volltext

P035. Melanoma chemotherapy leads to the selection of ABCB5-expressing cells von Chartrain, M., Riond, J., Stennevin, A., Vandenberghe, I., Gomes, B., Gairin, J.E., Guilbaud, N., Annereau, J.P.

Volltext

R51: Identification de biomarqueurs de l’agressivité du mélanome : le CD10 est associé avec un risque d’évolution métastatique rapide von Thomas, M., Lamant, L., Meyer, N., Annereau, J.P., Guilbaud, N., Paul, C., Brousset, P.

Volltext

Interest of colchicine for the treatment of cystic fibrosis patients. Preliminary report von Sermet-Gaudelus, I., Stoven, V., Annereau, J. P., Witko-Sarsat, V., Reinert, P., Guyot, M., Descamps-Latscha, B., Lallemand, J. Y., Lenoir, G.

Volltext